Evidence map›Paper›PMID 41735924›Full record

ArticleBMC pregnancy and childbirth2026

ANGPTL8 regulates glucose metabolism in gestational diabetes mellitus mice, and proteomic analysis reveals the PI3K/Akt pathway plays its role in insulin-resistance HepG

Xinping Xie, Jianying Yan, Xiaoyun Chen, Lidan He, Jianbo Wu, Lin Lu

Abstract read
In one paragraph

Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xinping Xie *College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, 350005, China.
Jianying YanCollege of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, 350005, China. yanjy2019@fjmu.edu.cn.
Xiaoyun Chen *Department of Obstetrics & Gynecology, the First Affiliated Hospital, Fujian Medical University, Fuzhou, 350005, China.
Lidan HeDepartment of Obstetrics & Gynecology, the First Affiliated Hospital, Fujian Medical University, Fuzhou, 350005, China.
Jianbo WuDepartment of Obstetrics & Gynecology, the First Affiliated Hospital, Fujian Medical University, Fuzhou, 350005, China.
Lin LuDepartment of Obstetrics & Gynecology, the First Affiliated Hospital, Fujian Medical University, Fuzhou, 350005, China.

Funding

2024 Fujian Province Joint Funds for Scientific and Technological Innovation (Guidance Project) 2023Y9096Startup Fund for scientific research, Fujian Medical University 2021QH1066
6 · The paper itself

Abstract

backgroundInsulin resistance (IR) is a pivotal determinant in the pathophysiological processes underlying gestational diabetes mellitus (GDM). Angiopoietin-like protein 8 (ANGPTL8) exhibits an ambiguous influence on glucose metabolism in the onset and progression of GDM. However, the functions of ANGPTL8 in the metabolic profiles of insulin-resistant (IR) HepG2 cells, glucose tolerance in GDM mice, and the possible underlying mechanisms require further exploration.

methodsANGPTL8 knockout and over-expressing HepG2 cell lines were established. Glucose uptake capacity in three clones (wild-type, ANGPTL8 knockout, and over-expressing) of insulin-resistant HepG2 cells was detected. Proteomic analysis of the IR HepG2 cells identified a cluster of relevant signaling pathways, and the effect of ANGPTL8 on metabolomic changes was evaluated. The GDM model was induced by a high-fat diet (HFD) and intraperitoneal injection of Streptozotocin (STZ) in pregnant mice. An oral glucose tolerance test (OGTT) was performed in both GDM mice and ANGPTL8 over-expressing GDM mice.

resultsThe PI3K/Akt signaling cascade was stimulated by insulin resistance, and this activation could be effectively suppressed by inhibitors targeting PI3K, Akt, and GSK-3β. HepG2 cells over-expressing ANGPTL8 and exposed to high insulin concentrations demonstrated a marked enhancement in glucose uptake capacity, as opposed to their wild-type counterparts or ANGPTL8 knockout cells under IR conditions. The most substantial down-regulation was observed in lactate and branched-chain amino acids (BCAAs), which exhibited a positive correlation with IR. Promoted translation of ANGPTL8 was found in the liver, pancreas, and placental tissues of GDM mice. Significantly better glucose tolerance was observed in GDM mice transfected with m-ANGPTL8 compared with those that were not. Furthermore, the activation of Akt was observed in the primary hepatocytes of ANGPTL8 over-expressing GDM mice.

conclusionOver-expression of ANGPTL8 may increase glucose uptake capacity and influence the metabolic profiles in IR HepG2 cells, enhancing the insulin-mediated activation of the PI3K/Akt/GSK-3β pathway. ANGPTL8 may improve glucose tolerance in GDM mice. These findings might contribute to a new understanding of the roles of ANGPTL8 in glucose metabolism during the onset and progression of insulin resistance, providing novel insights for the clinical therapy of GDM.

Indexed as

Angiopoietin-like ProteinsDiabetes, GestationalGlucoseInsulin ResistancePeptide HormonesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktAngiopoietin-Like Protein 8AnimalsFemaleGlucose Tolerance TestHep G2 CellsHumansMiceMice, Inbred C57BLMice, KnockoutAngiopoietin-Like Protein 8Angiopoietin-like ProteinsANGPTL8 protein, mouseGlucosePeptide HormonesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktAngiopoietin-like protein 8(ANGPTL8)Gestational diabetes mellitus(GDM)Insulin resistance(IR)MetabolomicsPI3K/ /Akt/GSK-3β signalingProteomics

Identifiers

PMID41735924
PMCPMC13041090

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.